Back to all cases

Defining Go-To-Market strategy for a novel immunoassay Point-of-care platform

Client description

French company developing an innovative technology allowing easy transfer of immunoassays onto portable systems.


The company wanted to evaluate the point-of-care application for infectious disease diagnosis, prioritize applications, select the tests of interest and define the Go-To-Market strategy.


Novoptim introduced the technology to KOLs, NGOs and Government agencies worldwide. Novoptim collected secondary data on competition and ran SWOT analysis for each market.


Tests of interest were identified and prioritized. The competitive landscape was assessed, and a Go-To-Market strategy was developed.